Cargando…

Prediction of response to immune checkpoint inhibitor therapy using 18F-FDG PET/CT in patients with melanoma

We aimed to assess serial (18)F-FDG PET/CT imaging according to morphological (RECIST1.1, iRECIST) and functional (PERCIST, PECRIT) criteria to predict clinical response to therapy in patients with advanced melanoma receiving immune checkpoint blocking agents. Retrospective data collection and analy...

Descripción completa

Detalles Bibliográficos
Autores principales: Amrane, Karim, Le Goupil, Delphine, Quere, Gilles, Delcroix, Olivier, Gouva, Sylvie, Schick, Ulrike, Salaun, Pierre-Yves, Abgral, Ronan, Alavi, Zarrin, Keromnes, Nathalie, Querellou, Solène
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708819/
https://www.ncbi.nlm.nih.gov/pubmed/31335691
http://dx.doi.org/10.1097/MD.0000000000016417

Ejemplares similares